Skip to main content

Diagnosis of Hepatitis D Virus Infection

  • Chapter

Part of the Medical Intelligence Unit book series (MIUN)

Abstract

Hepatitis D virus (HDV) is a small defective virus with a single stranded circular RNA of 1.7 kb in size1-3. Its hepatitis B surface antigen (HBsAg) envelope is provided by the helper hepatitis B virus (HBV) for successfiil package and transmission of HDV4,5. The antigenomic strand of HDV encodes a single protein, hepatitis delta antigen (HDAg) of two molecular weight forms. The large form HDAg with a 19-amino acid extension at the C-terminus plays a key role in the package of HDV and suppresses viral replication in a trans-dominant negative manner, while the small form plays an essential role in trans-activating the replication of HDV RNA.2,3

Keywords

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wang KS, Choo KL, Weiner AJ et al. Structure, sequence and expression of the hepatitis delta (£δ) viral genome. Science 1986; 323:508–512.

    CAS  Google Scholar 

  2. Modahl LE, Lai MMC. Hepatitis delta virus: The molecular basis of laboratory diagnosis. Critical Rev Clin Lab Sciences 2000; 37:45–92.

    CrossRef  CAS  Google Scholar 

  3. Taylor JM. Replication of human hepatitis delta virus: Recent developments. Trends Microbiol 2003; 11:185–190.

    CrossRef  PubMed  CAS  Google Scholar 

  4. Rizzetto M, Canese MG, Gerin JL et al. Transmission of hepatitis B virus-associated delta antigen to chimpanzee. J Infect Dis 1980; 141:590–602.

    PubMed  CAS  Google Scholar 

  5. Wu JC, Chen PJ, Kuo MYP et al. Production of hepatitis D virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991; 65:1099–1104.

    PubMed  CAS  Google Scholar 

  6. Wu JC, Chen TZ, Huang YS et al. Natural history of hepatitis D viral superinfection-significance of viremia detected by polymerase chain reaction. Gastroenterology 1995; 108:796–802.

    CrossRef  PubMed  CAS  Google Scholar 

  7. Hadler SC, De Monzo M, Ponzetto A et al. Delta virus infection and severe hepatitis: An epidemic in Yucpa Indians of Venezuela. Ann Intern Med 1984; 100:339–44.

    PubMed  CAS  Google Scholar 

  8. Govindarajan S, Chin KP, Redeker AG et al. Fulminant B viral hepatitis: Role of delta antigen. Gastroenterology 1984; 86:1417–1420.

    PubMed  CAS  Google Scholar 

  9. Wu JC, Chen CH, Hou MC et al. Multiple viral infections as the most common cause of fulminant and subfulminant viral hepatitis in an endemic area for hepatitis B: Application and limitations of polymerase chain reaction. Hepatology 1994; 19:836–840.

    PubMed  CAS  Google Scholar 

  10. Rizzetto M, Verme G, Recchia S et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983; 98:437–441.

    PubMed  CAS  Google Scholar 

  11. Govindarajan S, De Cock KM, Redeker AG. Natural course of delta superinfection in chronic hepatitis B virus-infected patients: Histologic study with multiple liver biopsies. Gastroenterology 1986; 6:640–644.

    CAS  Google Scholar 

  12. Wu JC, Lee SD, Govindarajan S et al. Correlation of serum delta RNA with clinical course of acute delta virus superinfection in Taiwan: A longitudinal study. J Infect Dis 1990; 161:1116–1120.

    PubMed  CAS  Google Scholar 

  13. Hadziyannis SJ, Hatzakis A, Paipaioannou C et al. Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res 1987; 234:181–202.

    PubMed  CAS  Google Scholar 

  14. Casey JL, Brown TL, Colan EJ et al. A genotype of hepatitis D virus that occurs in northern South America. Proc Acad Sci USA 1993; 90:9016–9020.

    CrossRef  CAS  Google Scholar 

  15. Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 1990; 64:5594–9.

    PubMed  CAS  Google Scholar 

  16. Wu JC, Choo KB, Chen CM et al. Genotyping of hepatitis D virus by restriction fragment length polymorphism and its correlation with outcomes of hepatitis D. Lancet 1995; 346:939–941.

    CrossRef  PubMed  CAS  Google Scholar 

  17. Lucey MR, Graham DM, Martin P et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut 1992; 33:1390–1396.

    PubMed  CAS  Google Scholar 

  18. Argona M, Macagno S, Carreda F et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1987; 1:478–480.

    CrossRef  Google Scholar 

  19. Huang YH, Wu JC, Sheng WY et al. Diagnostic value of anti-hepatitis D virus (HDV) antibodies revisited: A study of total and IgM anti-HDV compared with detection of HDV-RNA by poly merase chain reaction. J Gastroenterol Hepatol 1998; 13:57–61.

    PubMed  CAS  Google Scholar 

  20. Buti M, Esteban R, Jardi R et al. Clinical and serological outcome of acute delta infection. J Hepatol 1987; 5:50–64.

    CrossRef  Google Scholar 

  21. Hoofnagle JH. Type D (Delta) hepatitis. JAMA 1989; 261:1321–1325.

    CrossRef  PubMed  CAS  Google Scholar 

  22. Jardi R, Buti M, Rodriguez-Frias F et al. Clinical significance of two forms of IgM antibody to hepatitis delta virus. Hepatology 1991; 14:25–28.

    CrossRef  PubMed  CAS  Google Scholar 

  23. Buti M, Esteban R, Esteban JI et al. Anti-HD IgM as a marker of chronic delta infection. J Hepatol 1987; 4:62–5.

    CrossRef  PubMed  CAS  Google Scholar 

  24. Govindarajan S, Smedile A, Cock KMD et al. Study of reactivation of chronic hepatitis delta infection. J Hepatol 1989; 9:204–8.

    CrossRef  PubMed  CAS  Google Scholar 

  25. Farci. P, Gerin JL, Aragona M et al. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. JAMA 1986; 255:1443–6.

    CrossRef  PubMed  CAS  Google Scholar 

  26. Govindarajan S, Gupta S, Valinluck B et al. Correlation of IgM anti-hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV. Hepatology 1989; 10:34–5.

    CrossRef  PubMed  CAS  Google Scholar 

  27. Lau JYN, Smith HM, Chaggar K et al. Significance of IgM anti hepatitis D virus (HDV) in chronic HDV infection. J Med Virol 1991; 33:273–6.

    CrossRef  PubMed  CAS  Google Scholar 

  28. Jardi R, Buti M, Rodriguez F et al. Comparative analysis of serological markers of chronic delta infection: HDV RNA, serum HDAg and anti-HD IgM. J Virol Methods 1994; 50:59–66.

    CrossRef  PubMed  CAS  Google Scholar 

  29. Smedile A, Rizzetto M, Denniston K et al. Type D hepatitis: The clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology 1986; 6:1297–1302.

    CrossRef  PubMed  CAS  Google Scholar 

  30. Buti M, Esteban R, Roggendorf M et al. Hepatitis D virus RNA in acute delta infection: Serological profile and correlation with other markers of hepatitis D virus infection. Hepatology 1988; 8:1125–1129.

    CrossRef  PubMed  CAS  Google Scholar 

  31. Smedile A, Bergmann KF, Baroudy BM et al. Riboprobe assay for HDV RNA: A sensitive method for the detection of the HDV genome in clinical serum sample. J Med Virol 1990; 30:20–24.

    CrossRef  PubMed  CAS  Google Scholar 

  32. Tang JR, Cova L, Lamelin JP et al. Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction. J Hepatol 1994; 21:953–60.

    CrossRef  PubMed  CAS  Google Scholar 

  33. Madejon A, Castillo I, Bartolome J et al. Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection. J Hepatol 1990; 11:381–4.

    CrossRef  PubMed  CAS  Google Scholar 

  34. Jardi R. Buti M, Cotrina M et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 1995; 21:25–9.

    PubMed  CAS  Google Scholar 

  35. Negro F, Bonino F, Bisceglie AD et al. Intrahepatic markers of hepatitis delta virus infection: Study by in situ hybridization. Hepatology 1989; 10:916–920.

    CrossRef  PubMed  CAS  Google Scholar 

  36. Govindarajan S, Valinluck B, Peters RL. Relapse of acute B viral hepatitis: Role of delta agent. Gut 1996; 27:19–22.

    Google Scholar 

  37. Shattock AG, Morgan BM. Sensitive enzyme immunoassasy for the detection of delta antigen and anti-delta, using serum as the delta antigen source. J Med Virol 1984; 13:73–82.

    CrossRef  PubMed  CAS  Google Scholar 

  38. Cariani E, Ravaggi A, Puoti M et al. Evaluation of hepatitis delta virus RNA levels during interferon therapy by analysis of polymerase chain reaction products with a nonradioisotopic hybridization assay. Hepatology 1992; 15:685–689.

    CrossRef  PubMed  CAS  Google Scholar 

  39. Wu JC, Li CS, Chen CL et al. Factors associated with viremia and elevated transaminase levels in asymptomatic hepatitis D virus-infected risk groups. J Med Virol 1994; 42:86–90.

    CrossRef  PubMed  CAS  Google Scholar 

  40. Farci P, Mandas A, Colana A et al. Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994; 330:88–94.

    CrossRef  PubMed  CAS  Google Scholar 

  41. Wu JC, Chen CM, Sheen IJ et al. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 1995; 22:1656–1660.

    PubMed  CAS  Google Scholar 

  42. Wu JC, Chiang TY, Sheen IJ. Characterization and Phylogenetic analysis of a novel hepatitis D virus group discovered by restriction fragment length polymorphism. J General Virol 1998;78:1105–1113.

    Google Scholar 

  43. Lee CM, Bih FY, Chao YC et al. Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992; 188:265–73.

    CrossRef  PubMed  CAS  Google Scholar 

  44. Wu JC, Chiang TY, Shiue WK et al. Recombination of hepatitis D virus and its implications. Mol Biol Evol 1999; 16:1622–1632.

    PubMed  CAS  Google Scholar 

  45. Rizzetto M, Canese MG, Arico S et al. Immunofluorescence detection of a new antigen/antibody system (delta-antidelta) associated with the hepatitis B virus in the liver and in the serum of HBsAg carriers. Gut 1977; 18:997–1003.

    PubMed  CAS  Google Scholar 

  46. Recchia S, Rizzii R, Acquaviva F. Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica 1981; 73:773–777.

    PubMed  CAS  Google Scholar 

  47. Stocklin E, Gudat F, Krey G et al. δ-antigen in hepatitis B: Immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology 1981; 1:238–242.

    CrossRef  PubMed  CAS  Google Scholar 

  48. Kanel GC, Govindarajan S, Peters RL. Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med 1984; 101:51–54.

    PubMed  CAS  Google Scholar 

  49. Kuo MYP, Chao M, Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: Role of delta antigen. J Virol 1989; 63:1945–1950.

    PubMed  CAS  Google Scholar 

  50. Macnaughton TB, Gowans EJ, Jiber AR et al. Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology 1990; 177:696–698.

    CrossRef  Google Scholar 

  51. Wu JC, Chen CL, Lee SD et al. Expression and localization of the small and large delta antigens during the replication cycle of hepatitis D virus. Hepatology 1992; 16:1120–1127.

    PubMed  CAS  Google Scholar 

  52. Bichko VV, Taylor JM. Redistribution of the delta antigens in cells replicating the genome of hepatitis delta virus. J Virol 1996; 70:8064–8070.

    PubMed  CAS  Google Scholar 

  53. Hadziyannis SJ, Sherman M, Lieberman HM et al. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive chronic hepatitis B virus carriers. Hepatology 1985;5:544–547.

    CrossRef  PubMed  CAS  Google Scholar 

  54. Hsu SC, Syu WJ, Sheen IJ et al. Varied Assembly and RNA Editing Efficiencies between Geno types I and II Hepatitis D Virus and their Implications. Hepatology 2002; 35:665–672.

    CrossRef  PubMed  CAS  Google Scholar 

  55. Wu JC, Huang IA, Huang YS et al. Mixed genotypes infection of hepatitis D virus. J Med Virol 1999; 57:64–67.

    CrossRef  PubMed  CAS  Google Scholar 

  56. Hsu SC, Syu WJ, Ting LT et al. Immunohistochemical differentiation of hepatitis D virus genotypes. Hepatology 2000; 32:1111–1116.

    CrossRef  PubMed  CAS  Google Scholar 

  57. Smedile A, Rosina F, Saracco G et al. Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology 1991; 13:413–416.

    CrossRef  PubMed  CAS  Google Scholar 

  58. Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. Asian hepatitis lamivudine study group. N Engl J Med 1998; 339:61–68.

    CrossRef  PubMed  CAS  Google Scholar 

  59. Lau DT, Doo E, Par K et al. Lamivudine for chronic delta hepatitis. Hepatology 1999; 30:579–581.

    CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Landes Bioscience and Springer Science+Business Media

About this chapter

Cite this chapter

Wu, JC. (2006). Diagnosis of Hepatitis D Virus Infection. In: Hepatitis Delta Virus. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-35103-5_8

Download citation

Publish with us

Policies and ethics